The health registration for Nolevo, a morning after pill, seems to get KFDA approval around coming Nov. after the public hearing in Oct., said KFDA chief commissioner Yang Kyu-whan in the parliamentary inspection meeting on Sept. 11.
When the public hearing is considered as a nothing but a formal government administrative gesture, the product approval at KFDA for Nolevo, the first morning af...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.